About
Over the last eight years, over 800 pharmaceutical and medical device professionals have gathered in New York for intensive analysis of the latest legal developments on the product liability front. This event provides intimate networking opportunities, the wonders of New York City in December and the most comprehensive coverage of critical, cutting-edge legal issues. Join your peers and colleagues at The Plaza Hotel this December for the 9th annual event and get the information you need to succeed.
Contents & Contributors
COMPREHENSIVE UPDATE ON THE PREEMPTION DOCTRINE: WHAT DEFENSE COUNSEL MUST KNOW
Michael K. Brown, Reed Smith LLP
David G. Martin, Medtronic, Inc.
PROMOTION OF PRESCRIPTION DRUGS: TRAPS FOR THE UNWARY
Harvey L. Kaplan, Shook, Hardy & Bacon
Jon A. Strongman, Shook, Hardy & Bacon
RECORDS MANAGEMENT AND BEST PRACTICES IN E-DISCOVERY
Terry Tottenham, Fulbright & Jaworski LLP
Philip Lo Scalzo, Sanofi-Synthelabo
KEY ORDERS IN RE BAYCOL PRODUCTS LITIGATION (MDL 1431)
WORKING WITH CO-DEFENDANT PHYSICIANS TO MAXIMIZE MANUFACTURER DEFENSES
Beverly G. Baughman, Pfizer, Inc.
Kimberly S. Penner, McCarter & English
Jennifer Cortese Manus, McCarter & English
Suzanne D'Amico, McCarter & English
TORT REFORM IN 2004, THE NEW PARADIGM: REPRESENTING YOUR CLIENT OUTSIDE OF THE COURTROOM
Allen Waxman, Pfizer, Inc.
Diane E. Lifton, Gibbons, Del Deo, Dolan, Griffinger & Vecchione, P.C.
BATTEN DOWN THE HATCHES: THE LATEST MOVEMENTS OF THE PLAINTIFF'S BAR
Bruce R. Parker, Venable LLP
David S. Gray, Venable LLP
John L. Sander, Schering-Plough Corporation
NAVIGATING THE STICKY THICKET OF PROTECTIVE ORDERS
Kim M. Catullo, Gibbons, Del Deo, Dolan, Griffinger & Vecchione, P.C.
Diane E. Lifton, Gibbons, Del Deo, Dolan, Griffinger & Vecchione, P.C.
PREVENTING, PREPARING FOR AND DEFENDING DEPOSITIONS OF IN-HOUSE COUNSEL
Vickie L. Henry, Foley Hoag LLP
Lynn M. Zuchowski, Foley Hoag LLP
DRUG & MEDICAL DEVICE LITIGATION: PREVENTING, PREPARING FOR AND DEFENDING DEPOSITIONS OF IN-HOUSE COUNSEL
Vickie L. Henry, Foley Hoag LLP
Howard Dorfman, Bayer Pharmaceuticals Corporation
MASTERING THE MAZE OF DISCOVERY AGAINST RELATED FOREIGN CORPORATIONS IN A MULTI-NATIONAL CORPORATE WORLD
Bruce J. Hector, Becton, Dickinson and Company
Stuart M. Feinblatt, Sills Cummis Epstein & Gross P.C.
Tiffany N. Lee, Sills Cummis Epstein & Gross P.C.
SSRI LITIGATION: A BRIEF HISTORY
Linda Svitak, Faegre & Benson
DEPRESSION, SUICIDALITY, AND SSRI'S: FACT AND FICTION
Lanny Berman, Ph.D., ABPP, American Association of Suicidology
IMPLICATIONS FOR FDA-INITIATED LABEL CHANGES FOR PRODUCT LIABILITY LITIGATION
Michael J. Harrington, Eli Lilly and Company
DEFENDING SSRIs: STRATEGIES AND THEMES
Linda Svitak, Faegre & Benson
CLINICAL EXPERTISE IN MEDICAL PRODUCT LITIGATION: ON NOT "LOSING IN TRANSLATION"
Harold Bursztajn, MD, Harvard Medical School
EXPERTS – WHAT YOU DON'T KNOW CAN HURT YOU: "NO BOW TIES"
Frank C. Woodside, III, Dinsmore & Shohl LLP
Lori S. Drasnin, Dinsmore & Shohl LLP
Nicholas J. Kemphaus, Dinsmore & Shohl LLP
BRIEF OF AMICUS CURIAE PRODUCT LIABILITY ADVISORY COUNCIL ON BEHALF OF DEFENDANT-APPELLEE – HORN VS. THORATEC CORP
Publication Details